Leg braces put to the test for unsteady gait in ataxia
NCT ID NCT07720700
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study investigates whether custom lower limb orthoses (leg braces) can improve walking and balance in adults with cerebellar ataxia, a condition that affects coordination. Twenty participants will wear the braces at home and undergo tests like walking on a pressure-sensitive mat and a six-minute walk. The goal is to gather data that could help doctors make better decisions about prescribing orthoses for ataxia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lower limb orthoses (custom-fitted braces worn on the legs to support walking)
- What this could lead to
- If effective, this could provide evidence for using orthoses to improve mobility and stability in people with cerebellar ataxia.
- What could go wrong
- This is a small, early study with only 20 participants, so results may not apply to everyone. Orthoses can cause discomfort or skin issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cerebellar ataxia diagnosed by a physician * Ambulatory for 16 feet (Zeno mat) with assistance and without assistive device(s) * 18 years or older Exclusion Criteria: * Gait velocity \>/= 100 cm/sec without an assistive device * Medically diagnosed orthopedic conditions or injuries that impact ambulation * Unhealed wounds on the feet
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ataxia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75235, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a massive natural history study unlock the secrets of rare movement disorders?
- Can hope and trust boost engagement with rehab robots?
- Can brain stimulation sharpen Decision-Making in Parkinson's?
- Robots as rehab coaches: a new approach to retraining coordination in ataxia
- Can closing your eyes help you walk better? new rehab trial for nerve disorder
- Robot suit helps MS patients walk again – small study shows promise